Merck's Call To Action: Why Industry Should Embrace Health Reform

Industry has much to fear about some elements of health reform, like drug importation and price negotiation under Medicare Part D. But the risks of inaction are even greater. Pharmaceutical companies need to ensure that they have a place at the table-and come with a detailed plan on how health reform should work.